Navigation Links
GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years
Date:1/6/2009

ST. JOSEPH, Mich., Jan. 6 /PRNewswire/ -- GeneGo, Inc., a leading provider of software and high quality manually curated databases for systems biology and pathway analysis, today announced that Bayer Schering Pharma AG has renewed its MetaCore licenses for another three years. Bayer Schering Pharma has programs for cancer, cardiovascular diseases and gynecological therapies and GeneGo has good coverage of these diseases and others. GeneGo is also in the process of building disease specific platforms in cancer and the cardiovascular area that include blueprint pathway maps for the disease, processes and mechanisms as well as offering public domain experimental data and disease ontologies.

"Bayer Schering Pharma was one of our first customers and we appreciate their loyalty," said Julie Bryant, Vice President of Business Development at GeneGo. "MetaCore is widely used in Bayer in multiple departments including bioinformatics, oncology, cardiology and women's health for data mining and analysis of multiple omics experimental data such as gene expression and proteomics."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.1
'/>"/>

SOURCE GeneGo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology
2. GeneGo Is Awarded NCI Grant for Development of Systems Biology Database and Tools for Nutrition in Cancer in Collaboration with the FDA
3. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
4. University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence
5. Yale Keck Microarray Center Becomes a GeneGo Center of Excellence
6. Unilever Extends Their GeneGo MetaCore License
7. VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics
8. GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant
9. GSK Extends GeneGo License and Adds New Products
10. UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGos Platform
11. GeneGo Integrates With Cytoscape

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...oved the Promega PowerPlex 16 HS System for use by...ecords for the National DNA Index System. , ...FBI recently approved the Promega PowerPlex® ...g in, or generating DNA records for, the National ...ore than seven million profiles and has assisted i...
(Date:11/24/2009)...ientswithadvanced-stage,orrecurrentendometrialcanc...-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the"Co...docrinetherapyandoncology,todayannouncedpositiveef...peptideconjugate,AEZS-108(formerlyAN-152),inpatien...onalizedhealthcareapproach,thestudyselectedpatient...
(Date:11/24/2009)...Newswire-FirstCall/-HamiltonThorneLtd.(TSX-V:HTL),...cedlasersystemsandinstrumentsforthestemcellresearc...landfinancialresultsforthethirdquarterendedSeptemb...illioncomparedwith$1.43millioninQ32008,-Grossprofi...008,-Netlossreducedto$148,000comparedto$283,000inQ...
(Date:11/24/2009)...--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobalspeci...hassubmittedaMAAtotheEuropeanMedicinesAgencyfor,ve...pyindevelopment,forthetreatmentofType1Gaucherdisea...rasealfathathasbeensubmitted,withprevious,submissi...alsupplyshortageofthecurrentlyapprovedandmarketed,...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...SCHAUMBURG, Ill., May 14 Sagent Pharmaceuticals, ...pany, today announced that it,will contribute US$2...ims,of Monday,s earthquake in central China., "As...by the devastation,experienced by the people of th...executive officer, founder, and chairman of the bo...
...Phase 1c Study Demonstrates Dose-dependent Activit...gado Biosciences today announced,the Journal of Th...the,International Society on Thrombosis and Haemos... of the Company,s REG1 anticoagulation system.,REG...r-based anticoagulant,RB006, and its matched antid...
...SHANGHAI, China, May 14 /Xinhua-PRNewswire-FirstCa...T) ("China-Biotics," "the Company"), a leading,Chi...h, development,marketing and distribution of probi...gement will present at two upcoming investor confe...ll-China Conference in New York,City and the ROTH ...
Other Biology Technology:Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis 2Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis 3Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis 4China-Biotics, Inc. to Present at Two Upcoming Investor Conferences 2China-Biotics, Inc. to Present at Two Upcoming Investor Conferences 3
(Date:11/24/2009)...r of debate. A high-profile study a few years ago ... carbon from trees and leaves, evidence for a very...osystems. , But new research from the University.... Algae provide a much richer diet for fish and ot...this week in the Proceedings of the National Acad...
(Date:11/24/2009)...w research on bacterial communities throughout six... temporal patterns, suggesting that scientists cou... climate change in the polar regions. The study, p...onal Academy of Sciences Early Edition, shows tha...synchronously over time, correlating with seasonal...
(Date:11/24/2009)... . , The presence of increased body fat, and...s in the blood, hinders the loss and maintenance o...he University of Navarra conducted by Estbaliz Goy...y. , The project, entitled "A nutrigenetic and n...dy weight and inflammation," examines how the indi...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2It can be predicted the reaction obese patients will have to a diet 2Study suggests obesity alone does not cause knee osteoarthritis in mice 58434 1Study suggests obesity alone does not cause knee osteoarthritis in mice 58434 2Institute for Aging Research study links high heels to heel and ankle pain 58431 1Institute for Aging Research study links high heels to heel and ankle pain 58431 2Global Public Health the Focus of Scientific Conference 14273 1Global Public Health the Focus of Scientific Conference 14273 2Global Public Health the Focus of Scientific Conference 14273 3
...iversity of Maryland Center for Environmental Scie...e first able to quantify the amount of excess nitr...ntal restoration projects. This breakthrough will ...the pollution reducing benefits of stormwater mana...d to new nitrogen reduction opportunities as publi...
...nce on Climate Change (COP15) to be held in Copenh...e this conference as part of the run-up to the COP...nd capture some of the enormous research energy cu...on and adaption to climate change. Thus, the focus...e big issues,that the scientific community feels i...
...ncient human ancestor known as the "Nutcracker Man...early hominid diet. , Using high-powered microsco...on the teeth of several Nutcracker Man specimens a...nough to predict diet. , Peter Ungar, professor o...yetteville, contends the finding shows evolutionar...
Other Biology News:UMCES-led research team quantifies nutrient pollution reductions from urban stream restoration 2Ancient 'Nutcracker Man' challenges ideas on evolution of human diet 2Ancient 'Nutcracker Man' challenges ideas on evolution of human diet 3
Anti-Neurotensin Receptor Monoclonal Antibody, Unconjugated , Clone B-N6 from Cell Sciences
Congo Red Solution from ScyTek Laboratories
Anti-Dopamine D2 / D3 Receptor Polyclonal Antibody, Unconjugated from CHEMICON
Rabbit Anti-Factor IX Polyclonal Antibody, Unconjugated from Abcam
Biology Products: